Anion exchange stationary phases based on crosslinked hydroxyalkylamine layer and glycidol
10766026 ยท 2020-09-08
Assignee
Inventors
Cpc classification
B01J41/13
PERFORMING OPERATIONS; TRANSPORTING
C08L63/00
CHEMISTRY; METALLURGY
B01J47/022
PERFORMING OPERATIONS; TRANSPORTING
C08G73/0226
CHEMISTRY; METALLURGY
B01J41/20
PERFORMING OPERATIONS; TRANSPORTING
C08G73/024
CHEMISTRY; METALLURGY
International classification
B01J41/13
PERFORMING OPERATIONS; TRANSPORTING
C08L63/00
CHEMISTRY; METALLURGY
Abstract
An anion exchange stationary phase includes a negatively charged substrate particle, a base condensation polymer layer, a crosslinked ethanolamine condensation polymer, and a glycidol condensation layer. The crosslinked ethanolamine condensation polymer layer can be covalently attached to the base condensation polymer layer. The crosslinked ethanolamine condensation polymer layer can be formed by a condensation reaction product of a polyepoxide compound and ethanolamine. The glycidol condensation layer can be formed by the treatment of glycidol. The anion exchange stationary phase are suitable for separating a variety of haloacetic acids and common inorganic anions in a single chromatographic run in less than 20 to 35 minutes.
Claims
1. An anion exchange stationary phase formed by a method comprising: reacting a polyepoxide with a primary amine to form a base condensation polymer layer on a negatively charged substrate particle; reacting the base condensation polymer layer with a number of reaction cycles to form a crosslinked ethanolamine polymer layer, in which the number of reaction cycles ranges from three to ten and each reaction cycle includes a polyepoxide treatment followed by an ethanolamine treatment; and reacting the crosslinked ethanolamine polymer layer with a glycidol treatment.
2. The anion exchange stationary phase of claim 1, in which the method further comprises: treating the crosslinked ethanolamine polymer layer with a hydroxide solution before the glycidol treatment.
3. The anion exchange stationary phase of claim 1, in which the negatively charged substrate particles are contained as a packed bed in a first column, in which the reacting of the polyepoxide with the primary amine comprises: flowing a solution of the polyepoxide and the primary amine through the first column to form the base condensation polymer layer on the negatively charged substrate particles.
4. The anion exchange stationary phase of claim 3, in which the polyepoxide treatment comprises: flowing a solution of the polyepoxide through the first column; and the ethanolamine treatment comprises: flowing a solution of ethanolamine through the first column.
5. The anion exchange stationary phase of claim 4, in which the glycidol treatment comprises: flowing a solution of the glycidol through the first column.
6. The anion exchange stationary phase of claim 5, in which the solution of the glycidol is at a 10% concentration.
7. The anion exchange stationary phase of claim 1, in which the number of reaction cycles ranges from 3 to 4.
8. The anion exchange stationary phase of claim 1, in which the negatively charged substrate particle comprises a crosslinked divinylbenzene and ethylvinyl benzene particle, in which at least a surface of the negatively charged substrate particle includes sulfonate groups.
9. The anion exchange stationary phase of claim 1, in which the polyepoxide comprises a diepoxide compound.
10. The anion exchange stationary phase of claim 1, in which the polyepoxide comprises an alkyldiol diglycidyl ether.
11. The anion exchange stationary phase of claim 9, in which the diepoxide compound is 1,4-butanediol diglycidyl ether.
12. The anion exchange stationary phase of claim 1, in which the base condensation polymer layer is positively charged and ionically attached to the negatively charged substrate particle.
13. The anion exchange stationary phase of claim 1, in which the glycidol treatment is a single glycidol treatment.
Description
BRIEF DESCRIPTION OF THE DRAWINGS
(1) The accompanying drawings, which are incorporated herein and constitute part of this specification, illustrate presently preferred embodiments of the invention, and, together with the general description given above and the detailed description given below, serve to explain features of the invention (wherein like numerals represent like elements).
(2)
(3)
(4)
(5)
(6)
(7)
(8)
(9)
(10)
(11)
(12)
(13)
(14)
(15)
(16)
DETAILED DESCRIPTION OF EMBODIMENTS
(17) The following detailed description should be read with reference to the drawings, in which like elements in different drawings are identically numbered. The drawings, which are not necessarily to scale, depict selected embodiments and are not intended to limit the scope of the invention. The detailed description illustrates by way of example, not by way of limitation, the principles of the invention. This description will clearly enable one skilled in the art to make and use the invention, and describes several embodiments, adaptations, variations, alternatives and uses of the invention, including what is presently believed to be the best mode of carrying out the invention. As used herein, the terms about or approximately for any numerical values or ranges indicate a suitable dimensional tolerance that allows the part or collection of components to function for its intended purpose as described herein.
(18) Herein the term alkyl, by itself or as part of another substituent, means, unless otherwise stated, a straight or branched chain, or cyclic hydrocarbon radical, or combination thereof, which may be fully saturated, mono- or polyunsaturated and can include di- and multivalent radicals, having the number of carbon atoms designated (i.e., C.sub.1-C.sub.10 means one to ten carbons). Examples of saturated hydrocarbon radicals include, but are not limited to, groups such as methyl, ethyl, n-propyl (e.g., CH.sub.2CH.sub.2CH.sub.3, CH.sub.2CH.sub.2CH.sub.2), isopropyl, n-butyl, t-butyl, isobutyl, sec-butyl, cyclohexyl, (cyclohexyl)methyl, cyclopropylmethyl, homologs and isomers of, for example, n-pentyl, n-hexyl, n-heptyl, n-octyl, and the like. An unsaturated alkyl group is one having one or more double bonds or triple bonds. Examples of unsaturated alkyl groups include, but are not limited to, vinyl, 2-propenyl, crotyl, 2-isopentenyl, 2-(butadienyl), 2,4-pentadienyl, 3-(1,4-pentadienyl), ethynyl, 1- and 3-propynyl, 3-butynyl, and the higher homologs and isomers. The term alkyl, unless otherwise noted, is also meant to include those derivatives of alkyl defined in more detail below, such as heteroalkyl. Alkyl groups that are limited to hydrocarbon groups are termed homoalkyl. The term alkyl can also mean alkylene or alkyldiyl as well as alkylidene in those cases where the alkyl group is a divalent radical.
(19) Herein the term alkylene or alkyldiyl by itself or as part of another substituent means a divalent radical derived from an alkyl group, as exemplified, but not limited, by CH.sub.2CH.sub.2CH.sub.2 (propylene or propane-1,3-diyl), and further includes those groups described below as heteroalkylene. Typically, an alkyl (or alkylene) group will have from 1 to about 30 carbon atoms, preferably from 1 to about 25 carbon atoms, more preferably from 1 to about 20 carbon atoms, even more preferably from 1 to about 15 carbon atoms and most preferably from 1 to about 10 carbon atoms. A lower alkyl, lower alkylene or lower alkyldiyl is a shorter chain alkyl, alkylene or alkyldiyl group, generally having about 10 or fewer carbon atoms, about 8 or fewer carbon atoms, about 6 or fewer carbon atoms or about 4 or fewer carbon atoms.
(20) Herein the term alkylidene by itself or as part of another substituent means a divalent radical derived from an alkyl group, as exemplified, but not limited, by CH.sub.3CH.sub.2CH.sub.2 (propylidene). Typically, an alkylidene group will have from 1 to about 30 carbon atoms, preferably from 1 to about 25 carbon atoms, more preferably from 1 to about 20 carbon atoms, even more preferably from 1 to about 15 carbon atoms and most preferably from 1 to about 10 carbon atoms. A lower alkyl or lower alkylidene is a shorter chain alkyl or alkylidene group, generally having about 10 or fewer carbon atoms, about 8 or fewer carbon atoms, about 6 or fewer carbon atoms or about 4 or fewer carbon atoms.
(21) Herein the terms alkoxy, alkylamino and alkylthio (or thioalkoxy) are used in their conventional sense, and refer to those alkyl groups attached to the remainder of the molecule via an oxygen atom, an amino group, or a sulfur atom, respectively.
(22) Herein the term heteroalkyl, by itself or in combination with another term, means, unless otherwise stated, a stable straight or branched chain, or cyclic hydrocarbon radical, or combinations thereof, consisting of the stated number of carbon atoms and at least one heteroatom selected from the group consisting of O, N, Si, S and B, and wherein the nitrogen and sulfur atoms may optionally be oxidized and the nitrogen heteroatom may optionally be quaternized. The heteroatom(s) O, N, B, S and Si may be placed at any interior position of the heteroalkyl group or at the position at which the alkyl group is attached to the remainder of the molecule. Examples include, but are not limited to, CH.sub.2CH.sub.2OCH.sub.3, CH.sub.2CH.sub.2NHCH.sub.3, CH.sub.2CH.sub.2N(CH.sub.3)CH.sub.3, CH.sub.2SCH.sub.2CH.sub.3, CH.sub.2CH.sub.2, S(O)CH.sub.3, CH.sub.2CH.sub.2S(O)2-CH.sub.3, CHCHOCH.sub.3, Si(CH.sub.3).sub.3, CH.sub.2CHNOCH.sub.3, and CHCHN(CH.sub.3)CH.sub.3. Up to two heteroatoms may be consecutive, such as, for example, CH.sub.2NHOCH.sub.3 and CH.sub.2OSi(CH.sub.3).sub.3. Similarly, the term heteroalkylene by itself or as part of another substituent means a divalent radical derived from heteroalkyl, as exemplified, but not limited by, CH.sub.2CH.sub.2SCH.sub.2CH.sub.2 and CH.sub.2SCH.sub.2CH.sub.2NHCH.sub.2. For heteroalkylene groups, heteroatoms can also occupy either or both of the chain termini (e.g., alkyleneoxy, alkylenedioxy, alkyleneamino, alkylenediamino, and the like). Optionally, for alkylene and heteroalkylene linking groups, no orientation of the linking group is implied by the direction in which the formula of the linking group is written. For example, the formula CO.sub.2R optionally represents both C(O)OR and OC(O)R.
(23) Herein the terms cycloalkyl and heterocycloalkyl, by themselves or in combination with other terms, represent, unless otherwise stated, cyclic versions of alkyl and heteroalkyl, respectively. Additionally, for heterocycloalkyl, a heteroatom can occupy the position at which the heterocycle is attached to the remainder of the molecule. Examples of cycloalkyl include, but are not limited to, cyclopentyl, cyclohexyl, 1-cyclohexenyl, 3-cyclohexenyl, cycloheptyl, and the like. Examples of heterocycloalkyl include, but are not limited to, 1-(1,2,5,6-tetrahydropyridyl), 1-piperidinyl, 2-piperidinyl, 3-piperidinyl, 4-morpholinyl, 3-morpholinyl, tetrahydrofuran-2-yl, tetrahydrofuran-3-yl, tetrahydrothien-2-yl, tetrahydrothien-3-yl, 1-piperazinyl, 2-piperazinyl, and the like.
(24) Herein the terms halo or halogen, by themselves or as part of another substituent, mean, unless otherwise stated, a fluorine, chlorine, bromine, or iodine atom. Additionally, terms such as haloalkyl, are meant to include monohaloalkyl and polyhaloalkyl. For example, the term halo(C.sub.1-C.sub.4)alkyl is mean to include, but not be limited to, trifluoromethyl, 2,2,2-trifluoroethyl, 4-chlorobutyl, 3-bromopropyl, and the like.
(25) Herein the term aryl means, unless otherwise stated, a polyunsaturated, aromatic, substituent that can be a single ring or multiple rings (preferably from 1 to 3 rings), which are fused together or linked covalently. The term heteroaryl refers to aryl groups (or rings) that contain from one to four heteroatoms selected from N, O, S, Si and B, wherein the nitrogen and sulfur atoms are optionally oxidized, and the nitrogen atom(s) are optionally quaternized. A heteroaryl group can be attached to the remainder of the molecule through a heteroatom. Non-limiting examples of aryl and heteroaryl groups include phenyl, 1-naphthyl, 2-naphthyl, 4-biphenyl, 1-pyrrolyl, 2-pyrrolyl, 3-pyrrolyl, 3-pyrazolyl, 2-imidazolyl, 4-imidazolyl, pyrazinyl, 2-oxazolyl, 4-oxazolyl, 2-phenyl-4-oxazolyl, 5-oxazolyl, 3-isoxazolyl, 4-isoxazolyl, 5-isoxazolyl, 2-thiazolyl, 4-thiazolyl, 5-thiazolyl, 2-furyl, 3-furyl, 2-thienyl, 3-thienyl, 2-pyridyl, 3-pyridyl, 4-pyridyl, 2-pyrimidyl, 4-pyrimidyl, 5-benzothiazolyl, purinyl, 2-benzimidazolyl, 5-indolyl, 1-isoquinolyl, 5-isoquinolyl, 2-quinoxalinyl, 5-quinoxalinyl, 3-quinolyl, and 6-quinolyl. Substituents for each of the above noted aryl and heteroaryl ring systems are selected from the group of acceptable substituents described below.
(26) For brevity, herein the term aryl when used in combination with other terms (e.g., aryloxy, arylthioxy, arylalkyl) includes both aryl and heteroaryl rings as defined above. Thus, the term arylalkyl is meant to include those radicals in which an aryl group is attached to an alkyl group (e.g., benzyl, phenethyl, pyridylmethyl and the like) including those alkyl groups in which a carbon atom (e.g., a methylene group) has been replaced by, for example, an oxygen atom (e.g., phenoxymethyl, 2-pyridyloxymethyl, 3-(1-naphthyloxy)propyl, and the like).
(27) Each of the above terms (e.g., alkyl, heteroalkyl, aryl and heteroaryl) are meant to include both substituted and unsubstituted forms of the indicated radical. Preferred substituents for each type of radical are provided below.
(28) Substituents for the alkyl and heteroalkyl radicals (including those groups often referred to as alkylene, alkenyl, heteroalkylene, heteroalkenyl, alkynyl, cycloalkyl, heterocycloalkyl, cycloalkenyl, and heterocycloalkenyl) are generically referred to as alkyl group substituents, and they can be one or more of a variety of groups selected from, but not limited to: substituted or unsubstituted aryl, substituted or unsubstituted heteroaryl, substituted or unsubstituted heterocycloalkyl, OR, O, NR, NOR, NRR, SR, -halogen, SiRRR, OC(O)R, C(O)R, CO.sub.2R, CONRR, OC(O)NRR, NRC(O)R, NRC(O)NRR, NRC(O).sub.2R, NRC(NRRR)NR, NRC(NRR)NR, S(O)R, S(O).sub.2R, OS(O).sub.2R, S(O).sub.2NRR, NRSO2R, CN and NO.sub.2 in a number ranging from zero to (2m+1), where m is the total number of carbon atoms in such radical. R, R, R and R each preferably independently refer to hydrogen, substituted or unsubstituted heteroalkyl, substituted or unsubstituted aryl, e.g., aryl substituted with 1-3 halogens, substituted or unsubstituted alkyl, alkoxy or thioalkoxy groups, or arylalkyl groups. When a compound of the invention includes more than one R group, for example, each of the R groups is independently selected as are each R, R, R and R groups when more than one of these groups is present. When R and R are attached to the same nitrogen atom, they can be combined with the nitrogen atom to form a 5-, 6-, or 7-membered ring. For example, NRR is meant to include, but not be limited to, 1-pyrrolidinyl and 4-morpholinyl. From the above discussion of substituents, one of skill in the art will understand that the term alkyl is meant to include groups including carbon atoms bound to groups other than hydrogen groups, such as haloalkyl (e.g., CF.sub.3 and CH.sub.2CF.sub.3) and acyl (e.g., C(O)CH.sub.3, C(O)CF.sub.3, C(O)CH.sub.2OCH.sub.3, and the like).
(29) Similar to the substituents described for the alkyl radical, substituents for the aryl and heteroaryl groups are generically referred to as aryl group substituents. The substituents are selected from, for example: substituted or unsubstituted alkyl, substituted or unsubstituted aryl, substituted or unsubstituted heteroaryl, substituted or unsubstituted heterocycloalkyl, OR, O, NR, NOR, NRR, SR, -halogen, SiRRR, OC(O)R, C(O)R, CO2R, CONRR, OC(O)NRR, NRC(O)R, NRC(O)NRR, NRC(O).sub.2R, NRC(NRRR)NR, NRC(NRR)NR, S(O)R, S(O).sub.2R, S(O).sub.2NRR, NRSO.sub.2R, CN and NO.sub.2, R, N.sub.3, CH(Ph).sub.2, fluoro(C.sub.1-C.sub.4)alkoxy, and fluoro(C.sub.1-C.sub.4)alkyl, in a number ranging from zero to the total number of open valences on the aromatic ring system; and where R, R, R and R are preferably independently selected from hydrogen, substituted or unsubstituted alkyl, substituted or unsubstituted heteroalkyl, substituted or unsubstituted aryl and substituted or unsubstituted heteroaryl. When a compound of the invention includes more than one R group, for example, each of the R groups is independently selected as are each R, R, R and R groups when more than one of these groups is present.
(30) In an embodiment, sulfonated resin particles can be coated with a reaction product of 1,4-butanediol diglycidyl ether and methylamine to form a base layer on the sulfonated resin particles by electrostatic interaction. Next, four reaction cycles of 1,4-butanediol diglycidyl ether and ethanolamine were sequentially added to form a crosslinked layer that was hydrophilic and provides divalent anion selectivity. The crosslinked layer may be referred to as a hyperbranched polymer. To further improve the separation of haloacetic acids and common inorganic anions, two glycidol treatments were used in modifying the hyperbranched polymer. The addition of glycidol in the hyperbranched architecture provided an added benefit to improve its ability to pack the resin into column tubes. Such glycidol containing hyperbranched architectures are unusually easy to pack with a simple hydroxide packing solution, providing unusually high chromatographic performance compared to similar materials not containing glycidol. Hyperbranched materials not containing glycidol tend to be highly dilatent, shear thickening slurries, which tend to produce fronting peak shape when packed at optimum flow rates. It is believed that glycidol rich phases exhibit less repulsive interactions due to the shielding of the charged groups, which reduces shear thickening behavior and makes them easier to pack into a chromatography column. The resulting stationary phase has many available hydroxy groups to produce crosslinking across and also to aid in maintaining the hydrophilicity of the resin. The hydrophilic highly crosslinked polymer provides good selectivity for haloacetic acid separation along with common anions.
(31) Anion exchange stationary phases were synthesized with a crosslinked ethanolamine layer followed by a glycidol treatment that results in a chromatography resin capable of separating haloacetic acid and common inorganic anions in a relatively short single chromatographic run (e.g., less than 20 to 30 minutes). Not only are the chromatographic runs shorter with the anion exchange stationary phases described herein, but lower concentrations of eluent can be employed when performing the single chromatographic run. In general, lower eluent concentrations are desirable for reducing cost and chemical waste. Haloacetic acids are carboxylic acids in which a halogen atom takes the place of a hydrogen atom in acetic acid. Examples of haloacetic acids include monochloroacetic acid, dichloroacetic acid, trichloroacetic acid, bromoacetic acid, dibromoacetic acid, tribromoacetic acid, bromochloroacetic acid, bromodichloroacetic acid, and dibromochloroacetic acid. Common inorganic anions include bromate, bromide, chlorate, chloride, chlorite, fluoride, nitrate, nitrite, phosphate, sulfate, and, carbonate, which are often monitored in drinking water (e.g., EPA Method 300.0). It should be noted that anion exchange stationary phases may also be referred to interchangeably as anion exchange resins. The anions chlorite, bromate, and chlorate may also be referred to as oxyhalides.
(32) In an embodiment, a series of condensation polymer layers and condensation reaction products can be formed on a substrate. A polymer formed in a polymerization reaction with an amine and a polyepoxide may be referred to as a condensation polymer, condensation polymer reaction product, epoxy resin, or epoxy amine resin. Similarly, a condensation reaction product can be a product from a condensation reaction between a polymer and a reagent (e.g., epoxide or amine based reagent chemical). A polyepoxide includes a compound having two or more epoxide functional groups such as a diepoxide. An example of a polyepoxide may be an alkyldiol diglycidyl ether. Other examples of polyepoxides include butadiene diepoxide, ethyleneglycol diglycidyl ether, butanediol diglycidyl ether (e.g., 1,4-butanediol diglycidyl ether), diethyleneglycol diglycidyl ether, hexanediol diglycidyl ether, glycerol triglycidyl ether and numerous other compounds containing two or more epoxy groups including epoxy resins commonly used in commercial epoxy formulations.
(33)
(34)
(35) The negatively charged polymeric particle can be any inert polymeric substrate particle that is chemically stable under the intended conditions of use (e.g., pH 0 to 14). The polymeric particle may be based on a divinylbenzene (DVB) crosslinking monomer and a support resin monomer where the support resin monomer may be an ethylvinylbenzene (EVB) monomer, a styrene monomer, and a combination thereof. The mole percent of DVB can be 55% and EVB can be 45%. The support resin particles may have a diameter ranging from about 1 micron to about 20 microns, preferably from about 2 microns to about 10 microns, and more preferably from about 3 microns to about 7 microns. The support resin particles may have a surface area ranging from about 20 m.sup.2/g to about 800 m.sup.2/g, preferably from about 20 m.sup.2/g to about 500 m.sup.2/g, more preferably from about 20 m.sup.2/g to about 100 m.sup.2/g, and yet more preferably be about 20 m.sup.2/g to about 30 m.sup.2/g. The support resin particles may have a pore size ranging from about 1000 angstroms to about 2000 angstroms.
(36) In some embodiments, the negatively charged substrate particle may include one or more super macroporous particles (SMP). SMP can be obtained from commercial sources, including Agilent PLRP-s1000A and Waters Styragel HR4-HR6. The super macroporous particle can have a diameter of 4-6 m, a surface area of 20-30 m.sup.2/g, pore sizes of 1000 -2000 , and a crosslinking mole ratio of 55% of the divinylbenzene and a mole ratio of 45% of the ethylvinylbenzene.
(37) Alternatively, the polymeric particles may be based on other vinylaromatic monomers such as alpha-methylstyrene, chlorostyrene, chloromethylstyrene, vinyltoluene, vinylnaphthalene, and a combination thereof. The polymeric particles may also be based on unsaturated monomers, and copolymers of the above vinylaromatic monomers and unsaturated monomers. Preferably such monomers will be copolymerized with a vinylaromatic crosslinking monomer such as divinylbenzene but other vinylaromatic crosslinking monomers such as trivinylbenzene, divinylnaphthalene, and a combination thereof may also be used.
(38) The polymeric particles can be sulfonated to create a negative charge at least on the surface of the particle. For example, particles made with 45% DVB and 55% EVB can be sulfonated by treating the particles with glacial acetic acid and concentrated sulfuric acid.
(39) Referring back to
(40) For the first step a) of a first cycle, alkyldiol diglycidyl ether can be reacted with base layer 200 to form a first polyepoxide condensation reaction product (CRP) 300 having pendant epoxide groups 304, as illustrated in
(41) For a second step b) of the first cycle, the pendant epoxide groups 304 can be reacted with a first ethanolamine to form a first ethanolamine CRP 400, as illustrated in
(42) Now that one reaction cycle of two steps has been performed, a second cycle of two steps may be performed to create a hyperbranched structure. For a first step a) of a second cycle, the pendant hydroxy group 402 and the secondary amine compound 404 can be reacted with one alkyldiol diglycidyl ethers and two alkyldiol diglycidyl ethers, respectively, to form the second polyepoxide CRP (500b and 500a). The second polyepoxide CRP (500b and 500a) can be covalently attached to the first ethanolamine CRP 400. The second polyepoxide CRP (500b and 500a) includes a reaction product of i) an amine group 404 of the first ethanolamine CRP 400, and ii) a third polyepoxide compound. Under certain circumstances, the second polyepoxide CRP (500b and 500a) can further include a reaction product of i) a hydroxy group 402 of the first ethanolamine CRP 400, and ii) a third polyepoxide compound. As illustrated in
(43) For a second step b) of the second cycle, the pendant epoxide groups 504 can then be reacted with a second ethanolamine to form a second ethanolamine CRP 600 that has a pendant hydroxy group 602 along with a secondary amine 604, as illustrated in
(44) A third reaction cycle of two steps can be performed with the second ethanolamine CRP 600. For a first step a) of a third cycle, the pendant hydroxy group 602 and the secondary amine compound 604 can be reacted with one alkyldiol diglycidyl ethers and two alkyldiol diglycidyl ethers, respectively, to form the third polyepoxide CRP (not shown). The third polyepoxide CRP can be covalently attached to the second ethanolamine CRP 600. The third polyepoxide CRP includes a reaction product of i) an amine group of the second ethanolamine condensation reaction product, and ii) a fourth polyepoxide compound. It should be noted that the third polyepoxide CRP includes pendant epoxide groups and have a chemical structure analogous to the second polyepoxide CRP (500a and 500b of
(45) For a second step b) of the third cycle, the pendant epoxide groups of the third polyepoxide CRP can then be reacted with a third ethanolamine to form a third ethanolamine CRP (not shown). The third ethanolamine CRP can be covalently attached to the third polyepoxide condensation reaction product. The third ethanolamine CRP includes a reaction product of i) an epoxide group of the third polyepoxide condensation reaction product, and ii) a third ethanolamine. It should be noted that the third ethanolamine CRP would have a chemical structure analogous to the second ethanolamine CRP (600 of
(46) Similar to the third reaction cycle of two steps, a fourth reaction cycle can be performed with the third ethanolamine CRP. For a first step a) and a second step b) of the fourth cycle, the third ethanolamine CRP is reacted with alkyldiol diglycidyl ether and then a fourth ethanolamine to form a fourth polyepoxide CRP (not shown) and a fourth ethanolamine CRP (not shown). It should be noted that the fourth polyepoxide CRP and the ethanolamine CRP would have a chemical structure analogous to the second polyepoxide CRP (500a and 500b of
(47) In an embodiment, an anion exchange stationary phase includes a base layer 200 that is reacted with at least about three to about ten reactions cycles of reagents (diepoxide and ethanolamine), and preferably about three to about four reactions cycles of reagents to form a crosslinked ethanolamine polymer layer. The crosslinked ethanolamine condensation polymer layer can be covalently attached to the base condensation polymer. The crosslinked ethanolamine condensation polymer layer includes quaternary amines, ether groups, and hydroxy groups, as illustrated in
(48) Now that the crosslinked ethanolamine polymer layer has been formed, it can be reacted with a first glycidol and a second glycidol treatment to form the anion exchange stationary phase. In an embodiment, the first and second glycidol treatments can each include flowing a solution of the glycidol through the reaction column.
(49) A pendant hydroxy group (e.g., 602) and/or the secondary amine group (e.g., 604) of an ethanolamine CRP (e.g., 600 of
(50) To generate even more dihydroxy groups in the anion exchange resin, a second glycidol treatment can be used.
(51) In an embodiment, the crosslinked ethanolamine polymer layer can be reacted with two to ten, and preferably two to four sequential glycidol treatments to form a glycidol condensation layer that is covalently attached to the crosslinked ethanolamine condensation polymer layer. The glycidol condensation layer includes a plurality of dihydroxy groups, in which each dihydroxy group includes a first hydroxy group 702 and a second hydroxy group 704. The first hydroxy 702 is spaced from the second hydroxy 704 by the first two carbon spacer. At least a portion of the first hydroxy groups 702 is spaced from the quaternary amines of the crosslinked ethanolamine condensation polymer layer by the first two carbon spacer.
(52) In an embodiment, the hydroxyalkylamine can be in the form of ethanolamine 106 having a two carbon spacer (e.g., alkyl) with a terminal hydroxy group and terminal amine group. It should be noted that the hydroxy groups 202 and 302 (see
(53) It is worthwhile to note that the glycidol treatments reduces the population of beta hydroxide groups in the ion exchange resin, and thus, alters the anion binding characteristics of the anion exchange resin. During an anion chromatographic separation, a hydroxide eluent is typically used. When the pH of the hydroxide eluent is sufficiently high, the beta hydroxide can be deprotonated causing the ion exchange site to form a zwitterionic ion pair 902 (see e.g.,
Example 1Synthesis of the Anion Exchange Resin with Crosslinked Ethanolamine
(54) A 9250 mm (diameterlength) reaction column was packed with 6.5 m diameter particles with surface sulfonated (one hour at room temperature) 20.8 m.sup.2/g wide-pore resin (DVB/EVB). The base condensation layer was applied to a packed column by flowing a butanediol diglycidyl ether-methylamine solution mixture (10% (wt/wt %) with respect to butanediol diglycidyl ether: 4% (wt/wt %) with respect to methylamine) at 0.5 mL/minute through the column at 68 C. for 60 minutes to form a base condensation polymer 200 (see
Example 2Two Glycidol Treatments of the Anion Exchange Resin with Crosslinked Ethanolamine in the Chromatography Column
(55) The anion exchange resin with crosslinked ethanolamine was removed from the reaction column of Example 1 into a container and dispersed with physical force. 400 grams of 1 M NaOH was mixed with 20 grams of the anion exchange resin (1:20 ratio of resin to 1M NaOH, wt/wt %) in the container. The mixture was then sonicated to disperse the resin particles at room temperature for 60 minutes and then sieved and filtered. Next, the filter cake was washed with deionized water. The resulting filter cake formed a cleaned-up resin that was packed into 2250 mm chromatography columns.
(56) The following solutions were flowed into the 2250 mm packed chromatography columns at 0.1 mL/min. In step 1), deionized water was flowed for 5 minutes at 68 C. In step 2), 20% glycidol solution was flowed for 60 minutes at 68 C. to form the first glycidol condensation reaction product (e.g., 700a and 700b of
Example 3Glycidol Treatment of the Anion Exchange Resin with Crosslinked Ethanolamine in the Reaction Column
(57) The following solutions were flowed solution at 0.5 mL/minute into the 9250 mm reaction column of Example 1 containing anion exchange resin with crosslinked ethanolamine. In step 1), 0.1 M NaOH was flowed at room temperature for 30 minutes. In step 2), deionized water was flowed for 10 minutes at 68 C. In step 3), 20% glycidol solution was flowed for 60 minutes at 68 C. to form the first glycidol condensation reaction product (e.g., 700a and 700b of
Example 4Chromatogram of Standard Solution Containing Various Haloacetic Acids and Common Inorganic Anions
(58) A chromatography column of was installed into a Thermo Scientific Dionex ICS-5000.sup.+ ion chromatography system (commercially available from Thermo Fisher Scientific, Sunnyvale, Calif.). Three commercially available chromatography columns were used in the ion chromatography system (Thermo Scientific Dionex IonPac AS24, AS24A, and AS26). IonPac AS24, AS24A, and AS26 are anion exchange stationary phases that each includes a hyperbranched anion-exchange condensation polymer, electrostatically attached to the surface of a sulfonated wide-pore polymeric substrate. IonPac AS24, AS24A, and AS26 has alkanol quaternary ammonium functional groups and includes alternating treatments of epoxy monomer and methylamine to produce a coating that grows directly off of the substrate surface. In addition, the chromatography column of Examples 3 was also used. A pump was used to pump deionized water into a Thermo Scientific Dionex EGC 500 KOH cartridge (Thermo Fisher Scientific, Sunnyvale, Calif.) for generating a KOH gradient, which was different for each column type. The KOH gradient was optimized for each column to separate sulfate and phosphate from neighboring peaks. A temperature regulator was used to maintain a column temperature of 15 C. A Dionex AERS 500 suppressor (Thermo Fisher Scientific, Sunnyvale, Calif.) was used along with a Thermo Scientific conductivity detector. The Dionex AERS 500 suppressor typically uses a constant current to electrolyze water for regenerating the suppressor. Table 1 lists the relevant chromatographic system conditions for each type of chromatography column tested such as flow rate, injection volume, the gradient elution parameters, the suppressor format (for corresponding tubing diameter of the system), and applied current to the suppressor.
(59) TABLE-US-00001 TABLE 1 AERS Format Injection KOH (mm)/ Column Flow Rate Volume Time Concentration Current Type (mL/min) (L) (minutes) (mM) (mA) IonPac 0.25 2.5 0-7 5 2/56 AS24 7-16 5-25 16-27 25-90 27-45 90 Ion Pac 0.25 2.5 0-7 5 2/45 AS24A 7-15 5-35 15-30 35-45 30-50 45 IonPac 1.0 10 0-7 5 4/223 AS26 7-16 5-35 16-25 35-90 25-60 90 Example 3 0.25 2.5 0-7 5 2/35 7-16 5-25 16-23 25-55 23-40 55
(60) The chromatograms were run using a standard solution that contains the anions listed in Table 2 below.
(61) TABLE-US-00002 TABLE 2 Peak No. Anion mg/L 1 Fluoride 2.0 2 Monochloroacetate 10.0 3 Chlorite 10.0 4 Monobromoacetate 10.0 5 Bromate 20.0 6 Chloride 5.0 7 Dichloroacetate 30.0 8 Sulfate 20.0 9 Dibromoacetate 30.0 10 Nitrite 15.0 11 Phosphate 30.0 12 Chlorate 20.0 13 Bromide 20.0 14 Trichloroacetate 30.0 15 Nitrate 20.0 16 Tribromoacetate 30.0
(62)
Example 5Chromatograms of the Standard Solution Containing Various Common Inorganic Anions Comparing Glycidol Treatment in Chromatography Column (Example 2) to Glycidol Treatment in Reaction Column (Example 3)
(63) An ion chromatography system similar to Example 4 was employed with isocratic elution using a KOH eluent and a standard solution of common inorganic anions. The standard solution contained nine anions, which were fluoride 2.0 mg/L, chlorite 10.0 mg/L, bromate 20.0 mg/L, chloride 5.0 mg/L, sulfate 20.0 mg/L, nitrite 15.0 mg/L, chlorate 20.0 mg/L, bromide 20.0 mg/L, and nitrate 20.0 mg/L. A first chromatogram was performed using the column of Example 2 with 9 mM KOH eluent at 0.25 mL/min. A second chromatogram was performed using the column of Example 3 with 9 mM KOH eluent at 0.25 mL/min. Due to the co-eluting peaks of sulfate and nitrite, a third chromatogram was performed using the column of Example 3 with a higher 12 mM KOH eluent at 0.25 mL/min to separate sulfate and nitrite, so number of plates and asymmetry for sulfate can be measured accurately. The data from the first, second, and third chromatogram were shown in Table 3 below.
(64) TABLE-US-00003 TABLE 3 Retention Plates Asymmetry Plates Asymmetry Column KOH Eluent Time (minute) (EP) (AIA) (EP) (AIA) Pressure Concentration Flow Rate Column Nitrate Bromide Bromide Sulfate Sulfate (PSI) (mM) (mL/min) Comments First 37.13 4334 1.4 3259 1.27 2170 9 0.25 Glycidol Chromatogram Treatment In with Column of Chromatography Example 2 Column Second 35.75 6439 1.14 n/a n/a 2212 9 0.25 Glycidol Chromatogram Treatment In with Column of Reaction Column Example 3 Third 20.02 6859 1.1 5769 0.99 2197 12 0.25 Glycidol Chromatogram Treatment In with Column of Reaction Column Example 3
(65) The second chromatogram showed an improvement in the number of plates and asymmetry for bromide compared to the first chromatogram (from 4334 to 6439 plates, and from 1.4 to 1.14). The third chromatogram showed an improvement in the number of plates and asymmetry for sulfate compared to the first chromatogram (from 3259 to 5769 plates, and from 1.27 to 0.99). This chromatography column of Example 3 demonstrated that adding glycidol to the reaction column improves the subsequent packing of the chromatography columns, and results in a higher plate count and lower asymmetry compared to removing the ion exchange resin from the reaction column and then packing the chromatography column that is subsequently reacted with glycidol, as described in Example 2.
Example 6Chromatograms Using Anion Exchange Resins with Smaller Particles and a Standard Solution Containing Six Haloacetic Acids and Common Inorganic Anions
(66) Anion exchange resins were synthesized in manner similar to Example 1 except that three different types of particles were used in the synthesis to create three different resins, which were referred to as A (4.75 micron diameter, 26.3 m.sup.2/g, 4 hour at 80 C. sulfonation), B (4.55 micron diameter, 27.6 m.sup.2/g, 4 hour at 80 C. sulfonation), and C (4.6 micron diameter, 17.4 m.sup.2/g, 1 hour at room temperature sulfonation). In general, the particles used in Example 6 were smaller than Example 1, had different surface areas, and varying levels of sulfonation. The anion exchange resins of Example 6 were then treated in a manner similar to Example 3 except that a shorter 2150 mm chromatography column was used to further accelerate the chromatographic separation. The chromatography columns of Example 6 was tested in an ion chromatography system similar to Example 4. Table 4 lists the relevant chromatographic system conditions for this example such as flow rate, injection volume, the gradient elution parameters, the suppressor format (for corresponding tubing diameter of the system), and applied current to the suppressor.
(67) TABLE-US-00004 TABLE 4 AERS Format Injection KOH (mm)/ Column Flow Rate Volume Time Concentration Current Type (mL/min) (L) (minutes) (mM) (mA) A, B, or 0.25 2.5 0-4 5 2/31 C of Example 6 4-9 5-25 9-15 25-90 15-25 90
The chromatograms were run using a standard solution that contains the anions listed in Table 5 below.
(68) TABLE-US-00005 TABLE 5 Peak No. Anion mg/L 1 Fluoride 2.0 2 Monochloroacetate 10.0 3 Monobromoacetate 10.0 4 Bromate 20.0 5 Chloride 5.0 6 Dichloroacetate 30.0 7 Sulfate 20.0 8 Dibromoacetate 30.0 9 Nitrite 15.0 10 Phosphate 30.0 11 Chlorate 20.0 12 Bromide 20.0 13 Trichloroacetate 30.0 14 Nitrate 20.0 15 Tribromoacetate 30.0
(69)
Example 7Chromatograms of Standard Solution Containing Nine Haloacetic Acids and Common Inorganic Anions
(70) Anion exchange resins A and C of Example 6 was tested in an ion chromatography system similar to Example 4. Table 6 lists the relevant chromatographic system conditions for this example such as flow rate, injection volume, the gradient elution parameters, the suppressor format (for corresponding tubing diameter of the system), and applied current to the suppressor. The column temperature was maintained at a temperature of 15 C.
(71) TABLE-US-00006 TABLE 6 AERS Format Injection KOH (mm)/ Column Flow Rate Volume Time Concentration Current Type (mL/min) (L) (minutes) (mM) (mA) A of 0.25 2.5 0-4 4 2/28 Example 6 4-10 4-15 10-15 15-45 15-25 45 C of 0.25 2.5 0-4 4 2/28 Example 6 4-10 4-18 10-15 18-45 15-25 45
(72) The chromatograms were run using a standard solution that contains 9 haloacetic acids along with common inorganic anions listed in Table 7 below.
(73) TABLE-US-00007 TABLE 7 Peak No. Anion mg/L 1 Fluoride 1.0 2 Monochloroacetate 10.0 3 Chlorite 10.0 4 Monobromoacetate 10.0 5 Bromate 5.0 6 Chloride 1.5 7 Dichloroacetate 10.0 8 Bromochloroacetate 10.0 9 Sulfate 5.0 10 Dibromoacetate 10.0 11 Phosphate 10.0 12 Chlorate 5.0 13 Bromide 5.0 14 Trichloroacetate 10.0 15 Nitrate 5.0 16 Bromodichloroacetate 10.0 17 Chlorodibromoacetate 10.0 18 Tribromoacetate 10.0
(74)
Example 8Synthesis of the Anion Exchange Resin with Crosslinked Ethanolamine
(75) Anion exchange resin with crosslinked ethanolamine was synthesized in a manner similar to Example 1 except that the temperature of the reactions performed at 68 C. was increased to 72 C.
(76) A 9250 mm (diameterlength) reaction column was packed with 6.0 m diameter particles with surface sulfonated (one hour at room temperature) 20.8 m.sup.2/g wide-pore resin (DVB/EVB). The base condensation layer was applied to a packed column by flowing a butanediol diglycidyl ether-methylamine solution mixture (10% (wt/wt %) with respect to butanediol diglycidyl ether: 4% (wt/wt %) with respect to methylamine) at 0.5 mL/minute through the column at 72 C. for 60 minutes to form a base condensation polymer 200 (see
Example 9One Glycidol Treatment of the Anion Exchange Resin with Crosslinked Ethanolamine in the Chromatography Column
(77) A chromatography column was made with a process similar to Example 2. In this Example, the anion exchange resin of Example 8 was treated with only one glycidol treatment instead of the two glycidol treatments implemented in Example 2. In addition, a lower glycidol concentration was used in this Example compared to the glycidol concentration of Example 2.
(78) The anion exchange resin with crosslinked ethanolamine was removed from the reaction column of Example 8 into a container and dispersed with physical force. 400 grams of 1 M NaOH was mixed with 20 grams of the anion exchange resin (1:20 ratio of resin to 1M NaOH, wt/wt %) in the container. The mixture was then sonicated to disperse the resin particles at room temperature for 60 minutes and then sieved and filtered. Next, the filter cake was washed with deionized water. The resulting filter cake formed a cleaned-up resin that was packed into 2250 mm chromatography columns.
(79) The following solutions were flowed into the 2250 mm packed chromatography columns at 0.1 mL/min. In step 1), deionized water was flowed for 10 minutes at 68 C. In step 2), 10% glycidol solution (wt/wt % in water) was flowed for 60 minutes at 68 C. to form the first glycidol condensation reaction product (e.g., 700a and 700b of
Example 10Chromatograms of Standard Solution Containing Nine Haloacetic Acids and Common Inorganic Anions
(80) The anion exchange resin A of Example 6 and the anion exchange resin of Example 9 were tested in an ion chromatography system similar to Example 4. Table 8 lists the relevant chromatographic system conditions for this example such as flow rate, injection volume, the gradient elution parameters, the suppressor format (for corresponding tubing diameter of the system), and applied a constant current to the suppressor. The column temperature was maintained at a temperature of 15 C. A Dionex ADRS 600 suppressor (Thermo Fisher Scientific, Sunnyvale, Calif.) was used along with a Thermo Scientific conductivity detector. The Dionex ADRS 600 suppressor was used in a constant current mode to electrolyze water for regenerating the suppressor.
(81) TABLE-US-00008 TABLE 8 ADRS Format Injection KOH (mm)/ Column Flow Rate Volume Time Concentration Current Type (mL/min) (L) (minutes) (mM) (mA) A of 0.25 2.5 0-4 4 2/28 Example 6 4-10 4-15 10-15 15-45 15-25 45 Example 9 0.35 2.5 0-7 15 2/70 7-17 15-80 17-35 80
(82) The chromatograms were run using a standard solution that contains 9 haloacetic acids along with common inorganic anions listed in Table 9 below. It should be noted that Table 9 differs from Table 7 in that Table 9 does not include phosphate but does include nitrite.
(83) TABLE-US-00009 TABLE 9 Peak No. Anion mg/L 1 Fluoride 1.0 2 Monochloroacetate 10.0 3 Chlorite 10.0 4 Monobromoacetate 10.0 5 Bromate 5.0 6 Chloride 1.5 7 Sulfate 5.0 8 Dichloroacetate 10.0 9 Bromochloroacetate 10.0 10 Nitrite 10.0 11 Dibromoacetate 10.0 12 Chlorate 5.0 13 Bromide 5.0 14 Nitrate 5.0 15 Trichloroacetate 10.0 16 Bromodichloroacetate 10.0 17 Chlorodibromoacetate 10.0 18 Tribromoacetate 10.0
(84)
Example 11Chromatograms with the Anion Exchange Resin of Example 9 Using a Larger Sample Injection Volume of Standard Solution Containing Nine Haloacetic Acids and Common Inorganic Anions with Higher Concentrations
(85) The anion exchange resin of Example 9 was tested in an ion chromatography system similar to Example 10. Table 10 lists the relevant chromatographic system conditions for this example such as flow rate, injection volume, the gradient elution parameters, the suppressor format (for corresponding tubing diameter of the system), and the applied constant current to the suppressor. The column temperature was maintained at a temperature of 15 C.
(86) TABLE-US-00010 TABLE 10 ADRS Format Injection KOH (mm)/ Column Flow Rate Volume Time Concentration Current Type (mL/min) (L) (minutes) (mM) (mA) Example 9 0.35 100 0-7 15 2/70 7-17 15-80 17-35 80
(87) The chromatograms were run using either a standard solution A or a standard solution B as listed in Table 11 below. It should be noted that standard solution A has a generally lower concentration of anions than standard solution B except for fluoride, chlorate, and bromide. It should also be noted that the concentration of carbonate is denoted with a ? in standard solution A because it is relatively low and not well-defined. Although standard solution A has a lower concentration for various anions than the standard solution of Table 7, the larger injection volume of this Example causes the total amount injected for many of the haloacetic ions and common inorganic ions to be about the same (e.g., 2.5 L1 mg/L=100 l0.025 mg/L for fluoride). Standard solution B has a significantly higher concentration (e.g., greater than a factor of 100) for the common inorganic ions chloride, sulfate, carbonate, and nitrate than standard solution A. In particular, the concentration of chloride, sulfate, and nitrate in standard solution B are a factor of 9200, 2000, and 160 more than standard solution A, respectively. In general, it is undesirable to pre-treat the sample to remove high concentrations of matrix ions before performing a chromatographic run. Such pre-treatment steps can add cost and time to the measurement process and may inadvertently add imprecision to the analysis. It should be noted that the 100 L injection volume of this Example is significantly larger than the 2.5 L injection volume of the previous Example 10.
(88) TABLE-US-00011 TABLE 11 Std Std Peak Solution A Solution No. Anion (mg/L) B (mg/L) 1 Fluoride 0.025 0.0 2 Monochloroacetate 0.25 2.0 3 Monobromoacetate 0.25 2.0 4 Bromate 0.125 0.5 5 Chloride 0.038 350 6 Sulfate + carbonate 0.125 + ? 250 + 150 7 Dichloroacetate 0.25 2.0 8 Bromochloroacetate 0.25 2.0 9 Nitrite 0.25 0.5 10 Dibromoacetate 0.25 2.0 11 Chlorate 0.125 0.0 12 Bromide 0.125 0.0 13 Nitrate 0.125 20 14 Trichloroacetate 0.25 2.0 15 Bromodichloroacetate 0.25 2.0 16 Chlorodibromoacetate 0.25 2.0 17 Tribromoacetate 0.25 2.0
(89)
Example 12Chromatograms with the Anion Exchange Resin A of Example 6 Using a Larger Sample Injection Volume of Standard Solution Containing Nine Haloacetic Acids and Common Inorganic Anions Along with Higher Concentrations
(90) The anion exchange resin A of Example 6 was tested in an ion chromatography system similar to Example 11. Table 12 lists the relevant chromatographic system conditions for this example such as flow rate, injection volume, the gradient elution parameters, the suppressor format (for corresponding tubing diameter of the system), and the applied constant current to the suppressor. The column temperature was maintained at a temperature of 15 C. It should be noted that the 25 L injection volume of this Example was larger than the 2.5 L injection volume of Example 10, but is less than the 100 L injection volume of Example 11.
(91) TABLE-US-00012 TABLE 12 ADRS Format Injection KOH (mm)/ Column Flow Rate Volume Time Concentration Current Type (mL/min) (L) (minutes) (mM) (mA) Anion 0.25 25 0-4 4 2/28 Exchange Resin A of Example 6 4-10 4-15 10-15 15-45
(92)
(93) Although the anion exchange resin A of Example 6 had relatively poor performance in being able to separate nine haloacetic acids with a relatively high sample loading and a relatively high concentration of chloride, sulfate, carbonate, and nitrate, this anion exchange resin can be suitable for use in two dimensional chromatography where a portion of the matrix is removed in the first dimension. The anion exchange resin A of Example 6 provides an advantage over the anion exchange resin of Example 9 because it can separate can resolve chlorate from bromide, and monochloroacetate from chlorite. Examples of two dimensional chromatography can be found in U.S. Pat. No. 8,101,422, which is hereby incorporated by reference herein.
(94) While preferred embodiments of the present invention have been shown and described herein, it will be apparent to those skilled in the art that such embodiments are provided by way of example only. Numerous variations, changes, and substitutions will now occur to those skilled in the art without departing from the invention. While the invention has been described in terms of particular variations and illustrative figures, those of ordinary skill in the art will recognize that the invention is not limited to the variations or figures described. In addition, where methods and steps described above indicate certain events occurring in certain order, those of ordinary skill in the art will recognize that the ordering of certain steps may be modified and that such modifications are in accordance with the variations of the invention. Additionally, certain of the steps may be performed concurrently in a parallel process when possible, as well as performed sequentially as described above. Therefore, to the extent there are variations of the invention, which are within the spirit of the disclosure or equivalent to the inventions found in the claims, it is the intent that this patent will cover those variations as well.